Common (1% to 10%): Mild to moderate ovarian hyperstimulation syndrome (OHSS) (WHO grade I or II)Uncommon (0.1% to 1%): Severe ovarian hyperstimulation syndrome (WHO grade III)
Very common (10% or more): Nausea (12%)
The most commonly reported side effects were local injection site reactions such as erythema, swelling, and pruritus that were usually transient in nature and mild in intensity.
Uncommon (0.1% to 1%): Systemic allergic/pseudo-allergic reactions including life-threatening anaphylaxis
Common (1% to 10%): Redness, erythema, bruising, itching, swelling, pruritus (at the injection site)
Common (1% to 10%): Headache
Abdominal or stomach pain
 continuing or severe nausea, vomiting or diarrhea
decreased amount of urine
feeling of indigestion
moderate to severe bloating
pelvic pain, severe 
rapid weight gain
 shortness of breath
swelling of lower legs
Headache
injection site bruising, itching, swelling, or redness
nausea